LISA KNOLL: Open Payments
NPI 1740766500 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 28 payments from 14 companies in 2025. Trend: 2023 $643 · 2024 $688 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $158 |
| GlaxoSmithKline, LLC. | 8 | $153 |
| Madrigal Pharmaceuticals | 1 | $150 |
| PFIZER INC. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Novo Nordisk Inc | 2 | $55 |
| Ardelyx, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: UBRELVY, REZDIFFRA, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, Rybelsus, IBSRELA, VYNDAQEL.
Industry payments across CT — which companies pay providers there.
